||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 507 active entries
Lagoas Park, Edifício 7
2741-901, Porto Salvo, Oeiras
Phone: +351 21 422 0520
Fax: +351 21 422 0529
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Biotecnol is a private biopharmaceutical company focused on the development of biopharmaceuticals. Biotecnol has a special focus on the development of antibody-based therapeutics to treat life-threatening diseases such as cancer.
Biotecnol applies its technologies, product development and manufacturing experience to generate, support and potentially license human antibody products. Biotecnol is committed to building value by developing a diverse pipeline of antibody products to address unmet healthcare needs.
Biotecnol also leverages its business income by establishing in-house partner-led programmes. Biotecnol uses its proprietary expression technology, cell line development capabilities, upstream and downstream processing, analytics and QC experience for delivering GMP/GLP compliant processes for biomanufacturing. Biotecnol has several internal development programmes in oncology and a strong client-based activity with established track-record.
Last update of this entry: August 15, 2006